drugset / Trial / NCT03357133
Tirofiban for Patients Treated With Alteplase
RandomizedParallel-groupQuadruple-blindTreatment
Summary
After intravenous thrombolysis, the overall recanalization rate is 46%, and recclusion after initial recanalization occurs in 14-34%. In the MR TEA, the investigators compared the effects of administration of tirofiban in acute ischemic stroke patients treated with intravenous alteplase thrombolysis with alteplase alone.
Timeline
- Start
- 2017-12-16
- Primary completion
- 2020-06-01
- Completion
- 2020-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirofiban | Other / unclassified | — | — |
| Comparator | Alteplase | Protein / enzyme biologic | — | Intravenous |